HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 292/6/C2269    most recent 00441.2006v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Prasad, A. M. Articles by Inesi, G. Search for Related Content PubMed PubMed Citation Articles by Prasad, A. M. Articles by Inesi, G.

MUSCLE CELL BIOLOGY AND CELL MOTILITY

Phenylephrine hypertrophy, Ca²⁺-ATPase (SERCA2), and Ca²⁺ signaling in neonatal rat cardiac myocytes

¹California Pacific Medical Center Research Institute, San Francisco, California; and ²Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland

Submitted 16 August 2006 ; accepted in final form 30 January 2007

We endeavored to use a basic and well-controlled experimental system to characterize the extent and time sequence of sarco(endo)plasmic reticulum Ca²⁺-ATPase (SERCA) involvement in the development of cardiac hypertrophy, including transcription, protein expression, Ca²⁺ transport, and cytoplasmic Ca²⁺ signaling. To this end, hypertrophy of neonatal rat cardiac myocytes in culture was obtained after adrenergic activation with phenylephrine (PE). Micrographic assessment of myocyte size, rise of [¹⁴C]phenylalanine incorporation and total protein expression, and increased transcription of atrial natriuretic factor demonstrated unambiguously the occurrence of hypertrophy. An early and prominent feature of hypertrophy was a reduction of the SERCA2 transcript, as determined by RT-PCR with reference to a stable marker such as glyceraldehyde-3-phosphate dehydrogenase. Reduction of Ca²⁺-ATPase protein levels and Ca²⁺ transport activity to 50% of control values followed with some delay, evidently as a consequence of a primary effect on transcription. Cytosolic Ca²⁺ signaling kinetics, measured with a Ca²⁺-sensitive dye after electrical stimuli, were significantly altered in hypertrophic myocytes. However, the effect of PE hypertrophy on cytosolic Ca²⁺ signaling kinetics was less prominent than observed in myocytes subjected to drastic SERCA2 downregulation with small interfering RNA or inhibition with thapsigargin (10 nM). We conclude that SERCA2 undergoes significant downregulation after hypertrophic stimuli, possibly due to lack of SERCA gene involvement by the hypertrophy transcriptional program. The consequence of SERCA2 downregulation on Ca²⁺ signaling is partially compensated by alternate Ca²⁺ transport mechanisms. These alterations may contribute to a gradual onset of functional failure in long-term hypertrophy.

calcium adenosinetriphosphatase; calcium transport

This article has been cited by other articles:

				D. T. McCloskey, S. Turcato, G.-Y. Wang, L. Turnbull, B.-Q. Zhu, T. Bambino, A. P. Nguyen, D. H. Lovett, R. A. Nissenson, J. S. Karliner, et al. Expression of a Gi-coupled receptor in the heart causes impaired Ca2+ handling, myofilament injury, and dilated cardiomyopathy Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H205 - H212. [Abstract] [Full Text] [PDF]